Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

MYMETICS BV

Website:
mymetics.com
Headquarters:
Epalinges, VD, CH
Company Type:
Small Business (1-10M TTM Revenue)

MYMETICS: THE POWER OF A UNIQUE TECHNOLOGY TO DEVELOP NEXT-GENERATION PROPHYLACTIC VACCINES FOR INFECTIOUS DISEASES

Our vaccines are designed to induce protection against early transmission and infection, focusing both on the mucosal immune response as a first-line defense and the systemic humoral (blood) immune response, which, for some pathogens, may be essential for the development of an effective prophylactic vaccine. Our unique approach has resulted in the development of a rich pipeline of 5 vaccine candidates for HIV-1/AIDS, intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncytial Virus (RSV) vaccine. Our delivery platform is being validated through partnership with leading pharmaceutical or research organisations, including Astellas Pharma, PATH-MVI and the Bill and Melinda Gates Foundation. Mymetics Corporation (OTCQB: MYMX) is a Swiss based biotechnology company, with a Research Lab in the Netherlands. The company is registered in the US and trades on the OTCQB.

Site Badges
MYMETICS BV
21 J.H. Oortweg Leiden, ZH, 2333 CH Netherlands
MYMETICS BV
4 Route de la Corniche Epalinges, VD, 1066 Switzerland

Get started

If your organization has a Scientist.com marketplace, you can log in here to order products and services directly.

If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here.

To order products instantly, request access below.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service